Approval · Notice of Compliance 1814 · 1999
DALMANE: Notice of Compliance 1814
Issued January 25, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1814
- Date
- January 25, 1999
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph revisions
- Therapeutic class
- Hypnotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DALMANE | Not yet assigned | — |
Medicinal ingredients
- FLURAZEPAM HCL 15 MG per CAP
- FLURAZEPAM HCL 30 MG per CAP